Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Circulating procoagulant microparticles in obesity.

B Goichot1, L Grunebaum, D Desprez

  • 1Service de Médecine Interne et Nutrition, Hôpital de Hautepierre, Hôpitaux Universitaires, 67098 Strasbourg Cedex, France. bernard.goichot@chru-strasbourg.fr

Diabetes & Metabolism
|March 9, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Survival of patients managed in France for duodenal neuroendocrine tumors (D-NET): a 20-year multicenter cohort study from the GTE group: a cohort study.

International journal of surgery (London, England)·2024
Same author

Controversy: Pros and cons screening of corticotropic deficiency after exogenous glucocorticoid therapy.

Annales d'endocrinologie·2018
Same author

Subclinical haemorrhage in non-functional adenomas.

Neuro-Chirurgie·2018
Same author

An unusual pituitary stalk lesion: What is the place of surgery?

Neuro-Chirurgie·2017
Same author

Unraveling the intrafamilial correlations and heritability of tumor types in MEN1: a Groupe d'étude des Tumeurs Endocrines study.

European journal of endocrinology·2015
Same author

Clinical presentation of hyperthyroidism in a large representative sample of outpatients in France: relationships with age, aetiology and hormonal parameters.

Clinical endocrinology·2015

Obese individuals exhibit significantly higher levels of circulating procoagulant microparticles (MP), a potential indicator of thrombotic risk. This preliminary study highlights MP as a marker for obesity-associated vascular complications.

Area of Science:

  • Cardiovascular Science
  • Hematology
  • Metabolic Disorders

Background:

  • Obesity is a known risk factor for cardiovascular diseases and venous thromboembolism.
  • Circulating procoagulant microparticles (MP) are implicated in thrombosis and observed in diabetic patients.

Purpose of the Study:

  • To investigate the presence of MP in obese patients without other vascular risk factors, specifically excluding diabetes.
  • To evaluate MP levels as a potential biomarker in obesity-related thrombotic risk.

Main Methods:

  • A cohort of 58 obese women under 50 without cardiovascular risk factors was compared to 45 age-matched healthy controls.
  • MP levels were quantified and compared between groups.
  • Correlations between MP concentrations and insulin resistance markers were assessed in obese patients.

Related Experiment Videos

Main Results:

  • Obese patients (mean BMI 42.4 kg/m2) showed markedly higher MP levels than controls (10.6 vs 3.2 nMPSeq, P < 0.001).
  • A negative correlation was observed between MP levels and BMI in the obese group (r = -0.265, P < 0.05).
  • No significant relationship was found between MP concentrations and markers of insulin resistance.

Conclusions:

  • Elevated circulating MP levels in obesity suggest increased cell activation.
  • These findings indicate that MP may contribute to the heightened thrombotic risk associated with obesity.
  • Further research is warranted to explore MP relationships with coagulation and the impact of weight reduction.